Showing results (901-910 of 1,516) with videos related to

Sort By:
Pageof 152
Journal of Viral Hepatitis|November 6, 2012
IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donorsM Bes, S Sauleda, I Campos-Varela, et al.
ESMO Open|August 13, 2025
Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approachesM C de Grandis, I Baraibar, O Prior, et al.
Transfusion|October 19, 2001
Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making processJ L Arroyo, M A García-Marcos, A López, et al.
Current Opinion in Molecular Therapeutics|December 15, 2010
Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trialsHeinz Zwierzina, Alberto Bardelli, Fortunato Ciardiello, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2017
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotypeM Riveiro-Barciela, M Bes, F Rodríguez-Frías, et al.
Targeted Oncology|August 28, 2015
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid TumorsRodrigo Dienstmann, Ulrik Lassen, Jonathan Cebon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
ESMO-Magnitude of Clinical Benefit Scale version 1.1N I Cherny, U Dafni, J Bogaerts, et al.
Future Oncology (London, England)|February 16, 2019
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabineMohamad Bassam Sonbol, Daniel H Ahn, David Goldstein, et al.
The New England Journal of Medicine|June 4, 2004
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerThierry André, Corrado Boni, Lamia Mounedji-Boudiaf, et al.
Medicina Clinica|January 25, 1981
[A study of the urinary acidifying capacity of patients chronically treated with anticonvulsants (author's transl)]J M Tabernero Romo, J L Rodriguez Commes, J de Manueles, et al.
Pageof 152